Frontlight ResearchEarly access
Trial site
NCI - Center for Cancer Research
- 9running trials
- 2closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers3 trials
- Bladder cancer2 trials
- Kidney cancer2 trials
- Lung cancer2 trials
- Neuroendocrine tumours2 trials
- Sarcoma2 trials
- Acute myeloid leukaemia1 trial
- Head and neck cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 28 trials
- Phase 13 trials
- Status
- Active, not recruiting8 trials
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- National Cancer Institute (NCI)11 trials
Running trials
Recruiting
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
Active, not recruiting
Active, not recruiting
Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Kidney cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026